自体脂肪移植至原生乳房后的脂肪存活率:系统综述与荟萃分析
该系统综述与荟萃分析纳入47项研究共4425例受试者,评估自体脂肪移植至原生乳房(用于初次隆乳或乳房重建后对侧对称化)的结局。汇总脂肪坏死发生率为4.66%,每侧乳房脂肪移植存活率为53.26%,需额外脂肪移植率为11.83%,未来活检率为5.55%,研究间异质性显著。结论认为该操作安全、脂肪坏死率低且脂肪保留程度可接受,需告知患者容量丢失及可能需多次治疗。
要点
- 自体脂肪移植至原生乳房脂肪坏死汇总发生率为4.66%。
- 每侧乳房脂肪移植存活率汇总为53.26%。
- 需额外脂肪移植率11.83%,未来活检率5.55%。
核心结论
- 自体脂肪移植至原生乳房用于初次隆乳或对侧乳房重建后对称化是安全操作,脂肪坏死发生率低且脂肪保留程度可接受。
- 应告知患者存在容量丢失可能及可能需要多次治疗才能达到满意效果。
研究设计与样本
- 系统检索MEDLINE、Scopus、Embase、CINAHL、Cochrane Library和Google Scholar数据库。
- 采用随机效应模型计算汇总加权比例及95%CI,使用I2统计量评估异质性。
- 共纳入47项研究,合并受试者4425例。
主要发现
- 每例受试者脂肪坏死汇总发生率为4.66%(95%CI [1.88, 8.35],I2=91%)。
- 每侧乳房脂肪移植存活率为53.26%(95%CI [46.32, 60.20],I2=99.7%)。
- 需额外自体脂肪移植率为11.83%(95%CI [5.40, 20.12],I2=95.9%)。
- 未来活检率为5.55%(95%CI [0.53, 13.92],I2=81.6%)。
- 研究间观察到显著异质性。
临床怎么用
- 可依据汇总数据向患者说明脂肪坏死风险低、脂肪存活率约53%、可能需要额外移植。
- 术前咨询应强调容量丢失和多次治疗的可能性。
局限性
- 研究间异质性显著(如脂肪坏死I2=91%、脂肪存活I2=99.7%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous fat transfer (AFT) is increasingly used for breast augmentation, either for primary augmentation or symmetrization in the unaffected, native breasts following breast reconstruction. However, the incidence of fat necrosis and graft revascularization in this population remains unclear. A systematic review and meta-analysis were conducted to quantify these outcomes. Secondary outcome measures included the need for additional fat grafting and rate of subsequent biopsies. METHODS: A systematic search of the MEDLINE, Scopus, Embase, CINAHL, Cochrane Library, and Google Scholar databases was conducted. Pooled weighted proportions with 95% confidence intervals (CI) were calculated using a random-effects model. Heterogeneity was assessed using the I2 statistic. RESULTS: A total of 47 studies were included with a combined participant pool of 4425. The pooled incidence of fat necrosis per participant was 4.66% (95% CI [1.88, 8.35], I2 = 91%). Fat graft uptake per breast was 53.26% (95% CI [46.32, 60.20], I2 = 99.7%). The need for additional AFT was 11.83% (95% CI [5.40, 20.12], I2 = 95.9%). The rate of future biopsies was 5.55% (95% CI [0.53, 13.92], I2 = 81.6%). Considerable heterogeneity was observed across studies. CONCLUSIONS: AFT to the native breast for primary breast augmentation or symmetrization after contralateral breast reconstruction is a safe procedure with a low incidence of fat necrosis and an acceptable degree of fat retention. These findings highlight the importance of counseling patients regarding the likelihood of volume loss and potential need for multiple sessions to achieve satisfactory outcomes.
引用
- Giannas E, Fritsch AM, Jeon H, et al. Fat survival following autologous fat transfer to the native breast: A systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2026. PMID: 41791205. doi:10.1016/j.bjps.2026.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。